Showing results (101-110 of 129) with videos related to
Sort By:
Pageof 13
Leukemia|October 1, 1994
Cytosine arabinoside and mitoxantrone induction chemotherapy followed by bone marrow transplantation or chemotherapy for relapsed or refractory pediatric acute myeloid leukemiaR J Wells, S H Gold, C E Krill, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1985
Sequential high-dose cytosine arabinoside-asparaginase treatment in advanced childhood leukemiaR J Wells, J Feusner, R Devney, et al.Medical and Pediatric Oncology|January 1, 1994
Cytosine arabinoside and mitoxantrone treatment of relapsed or refractory childhood leukemia: initial response and relationship to multidrug resistance gene 1R J Wells, L F Odom, S H Gold, et al.Journal of Pediatric Hematology/Oncology|February 24, 2001
Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent or refractory solid tumors: a children's cancer group reportM S Cairo, V Shen, M D Krailo, et al.The Journal of Pediatrics|January 8, 1999
A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonatesM S Cairo, J Agosti, R Ellis, et al.Blood|May 29, 2000
Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemiaA J Barrett, O Ringdén, M J Zhang, et al.Bone Marrow Transplantation|June 29, 2010
Pericardial effusion post-SCT in pediatric recipients with signs and/or symptoms of cardiac diseaseM Neier, Z Jin, C Kleinman, et al.Leukemia|March 21, 2003
Elitek-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002P M Navolanic, C-H Pui, R A Larson, et al.Leukemia|April 18, 2002
Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group reportM S Cairo, M D Krailo, M Morse, et al.Bone Marrow Transplantation|January 20, 2004
A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipientsG Del Toro, P Satwani, L Harrison, et al.Pageof 13